ACE2 and infection: To examine whether ACE2 proteins efficiently protect against RSV infection in preclinical models, RSV BJ016 virus-infected WT mice were treated with recombinant hACE2 proteins (0.1 mg/kg)10 1 day before infection, as well as at 1 and 3 DPI.